Cited by 1,425Brain Metastases and TreatmentManagement of metastatic bone diseaseCancer survivorship and care

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Open access

Sperduto, Paul W., Kased, Norbert, Roberge, David, Xu, Zhiyuan, Shanley, Ryan, Luo, Xianghua, Sneed, Penny K., Chao, Samuel T., Weil, Robert J., Suh, John, Bhatt, Amit, Jensen, Ashley W., Brown, Paul D., Shih, Helen A., Kirkpatrick, John, Gaspar, Laurie E., Fiveash, John B., Chiang, Veronica, Knisely, Jonathan P.S., Sperduto, Christina Maria, Lin, Nancy, Mehta, Minesh·2012·Journal of Clinical Oncology

DOI 10.1200/jco.2011.38.0527PMC PMC3269967

Open this paper in CoChat — free account

Abstract

PURPOSE: Our group has previously published the Graded Prognostic Assessment (GPA), a prognostic index for patients with brain metastases. Updates have been published with refinements to create diagnosis-specific Graded Prognostic Assessment indices. The purpose of this report is to present the updated diagnosis-specific GPA indices in a single, unified, user-friendly report to allow ease of access and use by treating physicians. METHODS: A multi-institutional retrospective (1985 to 2007) database of 3,940 patients with newly diagnosed brain metastases underwent univariate and multivariate analyses of prognostic factors associated with outcomes by primary site and treatment. Significant prognostic factors were used to define the diagnosis-specific GPA prognostic indices. A GPA of 4.0 correlates with the best prognosis, whereas a GPA of 0.0 corresponds with the worst prognosis. RESULTS: Significant prognostic factors varied by diagnosis. For lung cancer, prognostic factors were Karnofsky performance score, age, presence of extracranial metastases, and number of brain metastases, confirming the original Lung-GPA. For melanoma and renal cell cancer, prognostic factors were Karnofsky performance score and the number of brain metastases. For breast cancer, prognostic factors were tumor subtype, Karnofsky performance score, and age. For GI cancer, the only prognostic factor was the Karnofsky performance score. The median survival times by GPA score and diagnosis were determined. CONCLUSION: Prognostic factors for patients with brain metastases vary by diagnosis, and for each diagnosis, a robust separation into different GPA scores was discerned, implying considerable heterogeneity in outcome, even within a single tumor type. In summary, these indices and related worksheet provide an accurate and facile diagnosis-specific tool to estimate survival, potentially select appropriate treatment, and stratify clinical trials for patients with brain metastases.

Integrity signals

Registry

Crossref · 10.1200/jco.2011.38.0527

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,858
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
Gaspar, L. E., Scott, C., Rotman, M., Asbell, S. O., Phillips, T. L., Wasserman, T. H., McKenna, W. G., & Byhardt, R. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,548
Self-citation
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
Sperduto, P. W., Berkey, B. A., Gaspar, L. E., Mehta, M. P., & Curran, W. J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031
Self-citation
An Introduction to Recursive Partitioning Using the RPART Routines
Therneau, T. M., & Atkinson, E. J. (2015) · Cited by 1,006
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J. H., Roberge, D., Bhatt, A. K., Jensen, A. W., Brown, P. D., Shih, H. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 987
Self-citation
Intracerebral metastases in solid-tumor patients: Natural history and results of treatment
Zimm, S., Wampler, G. L., Stablein, D., Hazra, T. A., & Young, H. F. (1981) · Cancer · doi:10.1002/1097-0142(19810715)48:2 · Cited by 597
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases
Gaspar, L. E., Scott, C., Murray, K., & Curran, W. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00547-2 · Cited by 531
Self-citation
Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases
Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J. H., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.027 · Cited by 367
Self-citation

Show all 21 references

Research works printed but not linked: 1

Therneau TM, 1997, Technical Report 61

Sorted by citations

Items 901–1,000 of 1,000

Tumors of the Central Nervous System
Suryadevara, R., Fadel, H., Michelhaugh, S. K., Mittal, S., & Parajuli, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812218-1.00001-4 · Cited by 6
Estimating Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Whole-brain Radiotherapy With a New Tool
Hansen, H. C., Janssen, S., Schild, S. E., & Rades, D. (2019) · Anticancer Research · doi:10.21873/anticanres.13321 · Cited by 6
Management evaluation of metastasis in the brain (MEMBRAIN)—a United Kingdom and Ireland prospective, multicenter observational study
Jung, J., Tailor, J. K., Dalton, E., Glancz, L. J., Roach, J., Zakaria, R., Lammy, S., Chari, A., Budohoski, K. P., Livermore, L. J., et al. (2019) · Neuro-Oncology Practice · doi:10.1093/nop/npz063 · Cited by 6
Stereotactic radiation therapy for breast cancer in the elderly
Jardel, P., Kammerer, E., Villeneuve, H., & Thariat, J. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.07.18 · Cited by 6
Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA)
Nieder, C., Hintz, M., Popp, I., Bilger, A., & Grosu, A. (2020) · Radiation Oncology · doi:10.1186/s13014-020-1484-9 · Cited by 6
An Easy-To-Use Survival Score Compared to Existing Tools for Older Patients with Cerebral Metastases from Colorectal Cancer
Rades, D., Nguyen, T. D., Janssen, S., & Schild, S. E. (2020) · Cancers · doi:10.3390/cancers12040833 · Cited by 6
Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience
Patil, R., Pandit, P., Palwe, V., Kate, S., Gandhe, S., Patil, R., Ramesh, Y. V., & Nagarkar, R. V. (2020) · European Journal of Breast Health · doi:10.4274/ejbh.2020.5969 · Cited by 6
Food and nutrition security: A literature review and prospects for research
Sun, Q., Li, X., Zhi-hai, Y. A. N. G., & Zhang, X. (2019) · 自然资源学报 · doi:10.31497/zrzyxb.20190817 · Cited by 6
Fatores prognósticos em metástases cerebrais do câncer de mama
Bastos, D. C. D. A. (2018) · doi:10.47749/t/unicamp.2018.1063270 · Cited by 6
Radiotherapy for brain metastases: 2025 update
Antoni, D., Mesny, E., Kabbaj, O. E., Josset, S., Quintin, K., Boue-Rafle, A., Tallet, A. R., & Latorzeff, I. (2025) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2025.104765 · Cited by 5
Opportunities and Challenges of Visual Large Language Models in Imaging Diagnostics: Lessons from Brain Metastasis Detection in Clinical MRI
Nelles, C., Zeid, N. E.-H. A., Terzis, R., Iuga, A.-I., Görtz, L., Spurek, M. A., Maintz, D. C., Lennartz, S., & Kottlors, J. (2026) · Diagnostics · doi:10.3390/diagnostics16050749 · Cited by 5
Brain metastases: Comparing clinical radiological differences in patients with lung and breast cancers treated with surgery
Armocida, D., Zancana, G., Bianconi, A., Cofano, F., Pesce, A., Ascenzi, B. M., Bini, P., Marchioni, E., Garbossa, D., & Frati, A. (2024) · World Neurosurgery X · doi:10.1016/j.wnsx.2024.100391 · Cited by 5
Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis
He, M., Wu, X., Li, L., Yi, G., Wang, Y., He, H., Ye, Y., Zhou, R., Xu, Z., & Yang, Z. (2025) · Radiation Oncology · doi:10.1186/s13014-024-02578-4 · Cited by 5
Self-citation
Revealing shared molecular drivers of brain metastases from distinct primary tumors
Fraga, C. A. D. C., Tiburske, L., da Silva, G. V. L., Simizo, A., Morais, M. C. C., Duarte, A. K. D. S. F., García, H. D. M., Hirata, T. D. C., & Nakaya, H. I. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149456 · Cited by 5
Non–Small-Cell Lung Cancer With CNS Metastasis: Disparities From a Real-World Analysis (GBOT-LACOG 0417)
Coelho, J. C., Carvalho, G. D. S., Chaves, F. F., Marchi, P. D., de Castro, G., Baldotto, C. S. D. R., Mascarenhas, E., Pacheco, P., de Jesus, R. G., Werutsky, G., et al. (2022) · JCO Global Oncology · doi:10.1200/go.21.00333 · Cited by 5
Recent Update on Neurosurgical Management of Brain Metastasis
Yoo, J., Park, H. H., Kang, S., & Chang, J. H. (2022) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2022.0023 · Cited by 5
Effectivity of involved-field radiotherapy for recurrent brain metastasis in patients with small-cell lung cancer
Wang, Y., Song, J., Li, W., Zeng, H., Liu, N., Zhu, S., Yuan, S., & Hu, X. (2022) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_185_22 · Cited by 5
Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer
Imaizumi, J., Shida, D., Boku, N., Igaki, H., Itami, J., Miyakita, Y., Narita, Y., Takashima, A., & Kanemitsu, Y. (2023) · International Journal of Clinical Oncology · doi:10.1007/s10147-023-02352-8 · Cited by 5
Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods
Yang, Z., Sun, R., Qu, G., Wang, F., Yin, Z., Zhang, T., Wang, P., Li, S., & Lin, S. (2023) · Translational Cancer Research · doi:10.21037/tcr-22-2715 · Cited by 5
Who should receive single-fraction palliative radiotherapy for gastric cancer bleeding?: An exploratory analysis of a multicenter prospective observational study (JROSG 17-3)
Sekii, S., Saito, T., Kosugi, T., Nakamura, N., Wada, H., Tonari, A., Ogawa, H., Mitsuhashi, N., Yamada, K., Takahashi, T., et al. (2023) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2023.100657 · Cited by 5
Association of the classification of intraoperative adverse events (ClassIntra) with complications and neurological outcome after neurosurgical procedures: a prospective cohort study
Drexler, R., Ricklefs, F. L., Pantel, T., Göttsche, J., Nitzschke, R., Zöllner, C., Westphal, M., & Dührsen, L. (2023) · Acta Neurochirurgica · doi:10.1007/s00701-023-05672-w · Cited by 5
Potential synergistic effects of cranial radiotherapy and atezolizumab in non-small cell lung cancer: an analysis of individual patient data from seven prospective trials
Guo, T., Zhou, Y., Liang, F., Wang, Z., Bourbonne, V., Käsmann, L., Sundahl, N., Wu, A. J.-C., Ni, J., & Zhu, Z. (2024) · Translational Lung Cancer Research · doi:10.21037/tlcr-23-792 · Cited by 5
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy
Bumpers, Q. A., Pipal, R. W., Benz-Weeden, A. M., Brewster, J. T., Cook, A., Crooks, A. L., Cruz, C. L., Dwulet, N. C., Gaudino, J. J., Golec, D., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01232 · Cited by 5
Outcomes of Brain Metastasis from Lung Cancer
Mobley, J. M., Phillips, K. I., Chen, Q., Reusch, E. M., Reddy, N., Magsam, J., McLouth, L. E. S., Huang, B., & Villano, J. L. (2025) · Cancers · doi:10.3390/cancers17020256 · Cited by 5
Population-based Analysis of Treatment and Survival in Women Presenting With Brain Metastasis at Initial Breast Cancer Diagnosis
Wiksyk, B., Nguyen, D. H. A., Alexander, C., & Truong, P. T. (2014) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000055 · Cited by 5
Brain Metastases From Melanoma: Therapy at the Crossroads
Kirkpatrick, J. P., Laack, N. N. I., Soltys, S. G., Halasz, L. M., Breneman, J. C., & Shih, H. A. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.06.005 · Cited by 5
Self-citation
Treating brain metastases in non-small cell lung cancer patients: what have we learnt from pharmaceutical recent clinical trials?
Liao, B.-C., Lin, C., & Yang, J. C. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1472765 · Cited by 5
Impact of diabetes mellitus on outcomes in patients with brain metastasis treated with stereotactic radiosurgery.
Mc, L., Er, M., Strowd, R. E., III, Lanier, C. M., Soike, M. H., Hughes, R. T., Masters, A. H., Cramer, C. K., Farris, M. K., Ruiz, J., et al. (2018) · Europe PMC (PubMed Central) · Cited by 5
Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
Xie, X., Peng, H., Zhang, X., Pan, Y., Zhang, Z., & Cao, P. (2022) · Radiation Oncology · doi:10.1186/s13014-022-02096-1 · Cited by 5
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non–Small Cell Lung Cancer
Jung, H. A., Park, S., Lee, S., Ahn, J. S., Ahn, M., & Sun, J. (2022) · Cancer Research and Treatment · doi:10.4143/crt.2022.1344 · Cited by 5
Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC
Krämer, A. S., Adeberg, S., Kronsteiner, D., König, L., Schunn, F., Bozorgmehr, F., Christopoulos, P., Eichkorn, T., Schiele, A., Hahnemann, L., et al. (2023) · Clinical Lung Cancer · doi:10.1016/j.cllc.2023.01.002 · Cited by 5
Principles of Lung Cancer Metastasis to Brain
Lucke-Wold, B. (2022) · Journal of Skeleton System · doi:10.58489/2836-2284/003 · Cited by 5
Glasgow prognostic score for assessing the efficacy of whole-brain radiation therapy in cases of recursive partitioning analysis class 2 and class 3 multiple brain metastases: a retrospective study
Ishikawa, Y., Umezawa, R., Yamamoto, T., Takahashi, N., Takeda, K., Suzuki, Y., Kishida, K., Omata, S., Teramura, S., Ito, K., et al. (2023) · Acta Neurologica Belgica · doi:10.1007/s13760-023-02384-x · Cited by 5
Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?
Estabrook, N. C., Lutz, S., Johnson, C. S., Lo, S. S.-M., & Henderson, M. A. (2016) · CNS Oncology · doi:10.2217/cns.15.45 · Cited by 5
Frameless stereotactic radiosurgery for brain metastases: a review of outcomes and prognostic scores evaluation
Mok, F., Kam, M. K. M., Tsang, W., Poon, D. M. C., Loong, H. H.-F., Yeung, W., Yeung, T., Yu, J. K. S., & Wong, C. K. H. (2017) · Hong Kong Medical Journal · doi:10.12809/hkmj166138 · Cited by 5
A Rare Clinical Presentation of Cholangiocarcinoma
Gravito‐Soares, E., Gravito‐Soares, M., Figueiredo, P., & Tomé, L. (2017) · Case Reports in Gastrointestinal Medicine · doi:10.1155/2017/7156838 · Cited by 5
The number of prior lines of systemic therapy as a prognostic factor for patients with brain metastases treated with stereotactic radiosurgery: Results of a large single institution retrospective analysis
Lanier, C. M., McTyre, E., LeCompte, M. C., Cramer, C. K., Hughes, R. T., Watabe, K., Lo, H., O’Neill, S. S., Munley, M. T., Laxton, A. W., et al. (2017) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2017.12.021 · Cited by 5
Radiation-induced cystic brain necrosis developing 10 years after linac-based stereotactic radiosurgery for brain metastasis
Aizawa, R., Uto, M., Takehana, K., Arakawa, Y., Miyamoto, S., & Mizowaki, T. (2018) · Oxford Medical Case Reports · doi:10.1093/omcr/omy090 · Cited by 5
Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome
Berliner, M. B.-Z., Yerushalmi, R., Lavie‏, I., Benouaich‐Amiel, A., Tsoref, D., Hendler, D., Goldvaser, H., Sarfaty, M., Rotem, O., Ulitsky, O., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05959-x · Cited by 5
Narrative review of immune checkpoint inhibitors and radiation therapy for brain metastases
Moskalenko, M., & Robin, T. P. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-3027 · Cited by 5
Volumetric modulated arc radiosurgery for brain metastases from breast cancer: A single-center study
Sánchez-Villalobos, J. M., Berna, A. S., Salinas-Ramos, J., Escolar, P. P., Martínez‐Alonso, E., Achel, D. G., & Alcaraz, M. (2021) · Colombia medica · doi:10.25100/cm.v52i3.4567 · Cited by 6
Efficacy and safety of apatinib combined with whole-brain radiation therapy with a simultaneous integrated boost for brain metastases from non-small cell lung cancer: a multicenter retrospective study
Ma, J., Bi, J., Tuo, X., Pi, G., Li, Y., Li, Y., Zeng, F., Gong, H., Hu, D., & Han, G. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-22-96 · Cited by 5
Micro-ribonucleic acids (miRNAs) and a proteomic profile in lung adenocarcinoma cases with brain metastasis
Zhang, L., Liang, J., Han, Z., Wang, L., Liang, J., & Zhang, S. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5703 · Cited by 5
Current advances in understanding and managing secondary brain metastasis
Dasararaju, R., & Mehta, A. (2012) · CNS Oncology · doi:10.2217/cns.12.33 · Cited by 5
Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations
Li, H., Lian, J., Hongxing, J., Wang, W., Cao, J., Zhang, X., Song, X., Jia, S., Jia, H., Ren, J., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2411-2 · Cited by 5
Benefit from the inclusion of radiation therapy in the treatment of patients with stage III classical Hodgkin lymphoma: A propensity matched analysis of the Surveillance, Epidemiology, and End Results database
Bates, J. E., Dhakal, S., Mazloom, A., Casulo, C., & Constine, L. S. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.016 · Cited by 5
Correction to: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR‑Mutant Lung Adenocarcinoma
Li, C., Zhang, B., Guo, J., Hu, F., Nie, W., Zheng, X., Wang, L., Lou, Y., Shen, Y., Han, B., et al. (2019) · Targeted Oncology · doi:10.1007/s11523-019-00659-z · Cited by 5
Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung‐molGPA) in a Chinese cohort: A retrospective study of multiple institutions
Ting-you, Z., Zhang, Y., Zhou, L., Deng, S., Huang, M., Liu, Y., Liu, Y., Gong, Y., Zhu, J., Xue, J., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3485 · Cited by 4
Programmed cell death 1 inhibitors with or without concurrent brain radiotherapy for lung cancer patients with brain metastases
Huang, Y., Li, H., Peng, L., Tong, F., Wen, L., Zhang, R., Cheng, S., & Dong, X. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-2334 · Cited by 4
Validation and discussion of clinical practicability of the 2022 graded prognostic assessment for NSCLC adenocarcinoma patients with brain metastases in a routine clinical cohort
Schröder, C., Windisch, P. Y., Lütscher, J., Zwahlen, D. R., & Forster, R. E. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1042548 · Cited by 4
The association between graded prognostic assessment and the prognosis of brain metastases after whole brain radiotherapy: a meta-analysis
Geng, X., Kou, C., & Wang, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1322262 · Cited by 4
Brain metastases in patients with salivary duct carcinoma: A retrospective study
Fushimi, C., Takahashi, H., Kawakita, D., Kano, S., Tsukahara, K., Ozawa, H., Okami, K., Sakai, A., Yamazaki, K., Okada, T., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.7037 · Cited by 4
Does 5-ALA Fluorescence Microscopy Improve Complete Resectability in Cerebral/Cerebellar Metastatic Surgery? A Retrospective Data Analysis from a Cranial Center
Sarkis, H. M., Alsofy, S. Z., Stroop, R., Lewitz, M., Schipmann, S., Unnewehr, M., Paulus, W., Nakamura, M., & Ewelt, C. (2024) · Cancers · doi:10.3390/cancers16122242 · Cited by 4
Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patients
Hosoya, K., Ozasa, H., Tanji, M., Yoshida, H., Ajimizu, H., Tsuji, T., Yoshida, H., Terada, Y., Sano, N., Mineharu, Y., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-12798-2 · Cited by 4
Hyperpolarized 13C lactate-to-bicarbonate signal ratio predicts brain metastases response to stereotactic radiosurgery
Cappelletto, N. I. C., Soliman, H., Uthayakumar, B., Sahgal, A., Bragagnolo, N. D., Chen, A. P., Endre, R., Ma, N., Perks, W. J., Detsky, J. S., et al. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf121 · Cited by 4
Clinical outcomes following stereotactic radiosurgery for brain metastases from sarcoma primaries: An international multicenter analysis
Singh, R. B., Roubil, J. G., Bowden, G. N., Mathieu, D., Carrier, L., Shepard, M. J., Kite, T. S., Wegner, R. E., Picozzi, P., Franzini, A., et al. (2025) · Cancer · doi:10.1002/cncr.35931 · Cited by 4
Self-citation
Unsupervised Clustering Successfully Predicts Prognosis in NSCLC Brain Metastasis Cohorts
Uysal, E., Durak, G., Sedef, A. K., Bağcı, U., Berber, T., Gürdal, N., & Yıldırım, B. A. (2025) · Diagnostics · doi:10.3390/diagnostics15141747 · Cited by 4
Multinational validation of distant metastasis velocity as a post-progression prognostic score in patients with oligometastatic cancer treated with metastasis-directed stereotactic body radiotherapy
Willmann, J., Baker, S., Chen, H., Dee, E. C., Badra, E. V., Christ, S. M., Mayinger, M. C., Ahmadsei, M., Adilovic, S., Das, S., et al. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.115737 · Cited by 4
New therapies for brain metastases: an update
Porte, M., & Massard, C. (2025) · Current Opinion in Oncology · doi:10.1097/cco.0000000000001195 · Cited by 4
Prognostic factors and survival outcome of brain metastases in breast cancer patients: a retrospective analysis
Durrani, S., Al-Ghamdi, A. A., Al-Bugawi, A., Alkhammash, A., Alhawish, M. K., Dabour, K., Al-Obaisi, Y., & Alrashidi, S. (2025) · BMC Cancer · doi:10.1186/s12885-025-14844-z · Cited by 4
Radiation therapy in the prevention and management of brain metastases in patients with small cell lung cancer: a narrative review
Hau, E. K. C., Lim, R., Vinod, S. K., Nahar, N., Gee, H. E., & Pinkham, M. B. (2021) · Chinese Clinical Oncology · doi:10.21037/cco-21-108 · Cited by 4
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
Cho, B. C., Kim, D., Batra, U., Park, K., Kim, S., Yang, C., Voon, P. J., Sriuranpong, V., Babu, K. G., Amin, K., et al. (2022) · Cancer Research and Treatment · doi:10.4143/crt.2021.1571 · Cited by 4
Phase I study of trametinib in combination with whole brain radiation therapy for brain metastases
Palmer, J. D., Prasad, R. N., Fabian, D., Wei, L., Yildiz, V. O., Tan, Y., Grecula, J. C., Welliver, M. X., Williams, T. M., Elder, J. B., et al. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.03.016 · Cited by 4
Prevalence and Prognostic Significance of Malnutrition in Patients with Brain Metastasis
Liu, Z., Zhang, Y., Pei, Y., He, Y., Yu, J., Zhang, R., Wang, J., Chong, W., Hai, Y., Peng, X., et al. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0918 · Cited by 4
Identification of FKBP10 prognostic value in lung adenocarcinoma patients with surgical resection of brain metastases: A retrospective single-institution cohort study
Liu, Z., Wang, S.-Q., Li, S., He, J., Wang, S., Cai, H., & Wan, J. (2023) · Clinics · doi:10.1016/j.clinsp.2023.100212 · Cited by 4
Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases
Jia, W., Zhai, X., Jing, X., Bao, Q., Xu, S., Zhu, H., Wu, G., & Yu, J. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04426-z · Cited by 4
Efficacy and survival outcomes of alectinib vs. crizotinib in ALK‑positive NSCLC patients with CNS metastases: A retrospective study
Liu, Q., Fu, Y., Guo, J., Fu, C., Tang, N., Zhang, C., Han, X. W., & Wang, Z. (2024) · Oncology Letters · doi:10.3892/ol.2024.14357 · Cited by 4
Assessing EGFR‐mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy
Chen, W., Cheng, W., Chen, C., Liao, W., Chen, C., Chen, H., Tu, C., Lin, C., & Hsia, T. (2024) · Cancer Medicine · doi:10.1002/cam4.7152 · Cited by 4
Brain Metastases in Sarcomas: A Multicenter Retrospective Cohort Study
Zhang, E., Farag, S., Dietz, H., Wang, D., Hirbe, A. C., Ganjoo, K. N., Tine, B. A. V., Zaid, S., Miah, A. B., Keedy, V. L., et al. (2024) · Cancers · doi:10.3390/cancers16223760 · Cited by 4
Efficacy and safety of combining anti-angiogenic therapy, radiotherapy, and PD-1 inhibitors in patients with driver gene-negative non-small cell lung cancer brain metastases: a retrospective study
Zhang, X., Sun, Q., Chen, R., Zhao, M., Cai, F., Cui, Z., & Jiang, H. (2024) · BMC Cancer · doi:10.1186/s12885-024-13264-9 · Cited by 4
Soins de support, cognition, qualité de vie et métastases cérébrales
Rhun, É. L., Taillibert, S., Blonski, M., Jouniaux-Delbez, N., Delgadillo, D., Taillia, H., Auquier, P., Belin, C., Bonnetain, F., Varin, D., et al. (2015) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2014.11.003 · Cited by 4
New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases
Li, J. (2012) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2012.10.024 · Cited by 4
Bilateral occipital metastases: Visual deficits and management considerations
Zaki, M. M., Gupta, S., Hauser, B. M., Wu, K. C., Mallery, R. M., Prasad, S., Aizer, A. A., Bi, W. L., & Dunn, I. F. (2020) · Surgical Neurology International · doi:10.25259/sni_487_2020 · Cited by 4
Surgical Indication Optimization of Brain Metastases Based on the Evolutionary Analysis of Karnofsky Performance Status
Rasmussen, J., Ajler, P. M., Massa, D., Plou, P., Baccanelli, M. M., & Yampolsky, C. (2021) · Journal of Neurological Surgery Part A Central European Neurosurgery · doi:10.1055/s-0040-1714410 · Cited by 4
Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung Adenocarcinoma
Li, C., Zhang, B., Guo, J., Hu, F., Nie, W., Zheng, X., Wang, L., Lou, Y., Shen, Y., Han, B., et al. (2019) · Targeted Oncology · doi:10.1007/s11523-019-00649-1 · Cited by 4
Tumors of the nervous system
Arnold, L. M., DeWitt, J. C., & Thomas, A. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00028-9 · Cited by 4
Frequency of social burden and underage children in neuro-oncological patients
Kamp, M. A., von Saß, C., Januzi, D., Dibué, M., Libourius, K., McLean, A. C. L., Baumgarten, P., McLean, A. L., Dinc, N., & Senft, C. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05338-1 · Cited by 4
The dosimetric parameters impact on local recurrence in stereotactic radiotherapy for brain metastases
Berthet, C., Lucia, F., Bourbonne, V., Schick, U., Lecouillard, I., Deroff, C. L., Barateau, A., de Crevoisier, R., & Castelli, J. (2024) · British Journal of Radiology · doi:10.1093/bjr/tqae029 · Cited by 4
Clinico–pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis
Hijazi, A., Mohanna, M., Sabbagh, S., Herrán, M., Dominguez, B. G., Sarna, K., & Nahleh, Z. A. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07321-x · Cited by 4
Evolutionary Trend Analysis of Research on Immunotherapy for Brain Metastasis Based on Machine-Learning Scientometrics
Hu, X., Deng, X., Xie, J., Zhang, H., Zhang, H., Feng, B., Zou, Y., & Wang, C. (2024) · Pharmaceuticals · doi:10.3390/ph17070850 · Cited by 4
Métastases cérébrales d’un cancer bronchique non à petites cellules : du traitement standardisé au traitement personnalisé
Chargari, C., & Dhermain, F. G. (2013) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(13)70452-x · Cited by 4
Prognostic Factors and Survival Outcomes of Lung Cancer Patients with Brain Metastasis: Experience of a Tertiary Cancer Centre
Tibdewal, A. R., & Pathak, R. S. (2016) · Journal of Brain Tumors & Neurooncology · doi:10.4172/2475-3203.1000106 · Cited by 4
Intensity-modulated radiation therapy for patients with 1 to 3 brain metastases in recursive partitioning analysis class 3
Yang, J., Zhan, W., Zhang, H., Song, T., Jia, Y., Xu, H., Lin, B., Lv, S., & Liang, X. (2017) · Medicine · doi:10.1097/md.0000000000007715 · Cited by 4
Quality of life and efficacy of temozolomide combined with whole-brain radiotherapy in patients with brain metastases from non-small-cell lung cancer
Lv, Y., Zhang, J., Liu, Z., Liang, N., & Tian, Y. (2018) · Molecular and Clinical Oncology · doi:10.3892/mco.2018.1622 · Cited by 4
Acute intracranial hypertension management in metastatic brain tumor: A French national survey
Mazerand, E., Gallet, C., Pallud, J., Meneï, P., & Bernard, F. (2019) · Neurochirurgie · doi:10.1016/j.neuchi.2019.07.003 · Cited by 4
Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours
Nagtegaal, S., Hulsbergen, A. F. C., van Dorst, E. B. L., Kavouridis, V. K., Jessurun, C. A. C., Broekman, M. L. D., Smith, T. R., & Verhoeff, J. J. C. (2020) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2020.05.001 · Cited by 4
Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms
Díaz, B. C., Salmerón‐Moreno, K., Alvarez‐Alvarez, A., Mendoza-Olivas, L. G., Alvarado‐Miranda, A., Villarreal-Garza, C. M., Reynoso‐Noverón, N., Chávez‐MacGregor, M., & Meneses-Garcia, A. (2020) · Cancer · doi:10.1002/cncr.32928 · Cited by 4
ALK-Brain Prognostic Index—Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases
Tsakonas, G., Kamali, C., Petris, L. D., Friesland, S., Lewensohn, R., & Ekman, S. (2020) · Cancers · doi:10.3390/cancers12071804 · Cited by 4
Investigation of patent foramen ovale as a mechanism for brain metastasis in patients without prior lung involvement
Levin-Epstein, R. G., Kumar, P., Rusheen, J., Fleming, R. G., McWatters, Z., Kim, W. B., Kaprealian, T. B., West, B. H., & Tobis, J. M. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02471-y · Cited by 4
Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with gamma knife radiosurgery
van Ruitenbeek, N. J., Ho, V. K. Y., Westgeest, H. M., Beerepoot, L. V., & Hanssens, P. E. J. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03793-9 · Cited by 4
Successful treatment of 2 patients with brain metastases from non-small cell lung cancer with epidermal growth factor receptor mutation receiving dacomitinib
Zhao, S., Cong, X., & Liu, Z. (2021) · Medicine · doi:10.1097/md.0000000000026680 · Cited by 4
The Usefulness of Prognostic Tools in Breast Cancer Patients with Brain Metastases
Kufel-Grabowska, J., Niwińska, A., Radecka, B. S., Ali, S., Mandat, T. S., & Duchnowska, R. (2022) · Cancers · doi:10.3390/cancers14051099 · Cited by 4
Actual, Personalized Approaches to Preserve Cognitive Functions in Brain Metastases Breast Cancer Patients
Konopka‐Filippow, M., Hempel, D., & Sierko, E. (2022) · Cancers · doi:10.3390/cancers14133119 · Cited by 4
The Comprehensive Complication Index (CCI) as a Measure of Postoperative Morbidity and Neurologic Outcome after Elective Intracranial Surgery
Drexler, R., Ricklefs, F. L., Pantel, T., Göttsche, J., Westphal, M., & Dührsen, L. (2022) · Journal of Neurological Surgery Part A Central European Neurosurgery · doi:10.1055/a-1962-0636 · Cited by 4
New insights into HER2-low breast cancer brain metastasis: A retrospective analysis
Xu, H., Wang, Y., Li, L., Han, Y., Wu, Y., Sa, Q., Xu, B., & Wang, J. (2024) · The Breast · doi:10.1016/j.breast.2023.103669 · Cited by 4
Brain Metastasis from Solid Tumors
Bashour, S. I., William, W. N., Patel, S. P., Rao, G., Strom, E. A., McAleer, M. F., Guha‐Thakurta, N., Conrad, C. A., & Ibrahim, N. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801419-6.00001-x · Cited by 4
Intracranial Mass Lesions
Tarulli, A. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-29632-6_23 · Cited by 4
Which Prognostic Index Is Most Appropriate in the Setting of Delayed Stereotactic Radiosurgery for Brain Metastases?
Malouff, T. D., Bennion, N. R., Verma, V., Martinez, G. A., Balkman, N., Bhirud, A. R., Smith, T. C., & Lin, C. H. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00248 · Cited by 4
Historical perspectives on the biology of brain metastasis
Waters, J. D., Hoshide, R., & Jandial, R. (2017) · Clinical & Experimental Metastasis · doi:10.1007/s10585-017-9859-5 · Cited by 4
Can anticancer chemotherapy promote the progression of brain metastases?
Amelot, A., Terrier, L., Mathon, B., Cook, A., Mazeron, J., Valery, C., Cornu, P., Lévêque, M., & Carpentier, A. C. (2018) · Medical Oncology · doi:10.1007/s12032-018-1097-4 · Cited by 4

Authors: Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., Bhatt, A., Jensen, A. W., Brown, P. D., Shih, H. A., Kirkpatrick, J., Gaspar, L. E., Fiveash, J. B., Chiang, V., Knisely, J. P. S., Sperduto, C. M., Lin, N., & Mehta, M.
Affiliations: University of Minnesota (US)
University of California, San Francisco (US)
McGill University (CA)
Cleveland Clinic (US)
Author affiliations appear at the end of this article.
Mayo Clinic (US)
Harvard University (US)
Duke University (US)
University of Colorado Denver (US)
University of Alabama at Birmingham (US)
Yale University (US)
Hofstra University (US)
Dartmouth College (US)
Northwestern University (US)
ORCID: Sperduto, Paul W.
Kased, Norbert
Roberge, David
Xu, Zhiyuan
Shanley, Ryan
Luo, Xianghua
Sneed, Penny K.
Chao, Samuel T.
Weil, Robert J.
Suh, John
Bhatt, Amit
Brown, Paul D.
Shih, Helen A.
Kirkpatrick, John
Fiveash, John B.
Chiang, Veronica
Knisely, Jonathan P.S.
Mehta, Minesh
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2012-02-01
Volume: 30
Issue: 4
Pages: 419-425
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2011.38.0527
PMC: PMC3269967
OpenAlex: W1974820090
Cited by: 1,425
References: 21
Citations by year: 2026: 41 · 2025: 57 · 2024: 88 · 2023: 112 · 2022: 103 · 2021: 113 · 2020: 146 · 2019: 117 · 2018: 131 · 2017: 134 · 2016: 115 · 2015: 94 · 2014: 68 · 2013: 62 · 2012: 38
FWCI: 45.80
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Journal of Clinical Oncology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P30CA-77598, P30CA077598)
Topics: Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
Health Sciences › Medicine › Surgery › Management of metastatic bone disease
Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords: brain metastases, Graded Prognostic Assessment, prognosis, survival estimation, prognostic factors, lung cancer, melanoma, renal cell carcinoma, breast cancer, gastrointestinal cancer, Karnofsky performance status, extracranial metastases, number of brain metastases, clinical trial stratification
MeSH terms: Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Female, Humans, Kidney Neoplasms, Lung Neoplasms, Male, Melanoma, Neoplasm Metastasis, Prognosis, Retrospective Studies, Survival Analysis, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks